Deerfield Management Company — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions.
AI & Machine LearningBiotechDeep Tech
David Breckenridge(Founder)inDavid B. Goldstein(Founder)
Co-investorsCanaan PartnersDroia VenturesEcoR1 Capital
Cortica provides in-home, in-clinic, and telehealth neurological therapies for children with autism and developmental differences, integrating neurological, biomedical, behavioral, speech-language, and sensorimotor treatments.
Digital HealthHealthtechMedical DevicesSan Diego, US
Dr. Suzanne Goh(Founder)Neil Hattangadi(Co-Founder and Chief Executive Officer)inBriana Elvaiah(Executive Officer)inSuzanne Goh-Hattangadi(Founder)Suzanne Goh, MD, BCBA(Co-Founder and Chief Medical Officer)
BoardRyan Drant(Director)in
Co-investors.406 VenturesAIFAPERTURE Venture PartnersCVS Health VenturesEcho Health VenturesLongitude Capital+6 more
Teambit analyzes code, meeting time, and interactions to measure and improve the performance of software development teams, delivering objective metrics.
AI & Machine LearningDeveloper ToolsSaaS
Paula Enei(Founder)in
Co-investorsGG Capital4BIO CapitalGeneral CatalystMRL Ventures FundNorwest Venture PartnersNovo Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bitterroot Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














.png)